In this trial, participants will be given dexmedetomidine using a single-arm study design. fMRI will be conducted during this time. Cognitive assessments and pain monitoring will be administered at various points before and after dexmedetomidine is administered.
Neuroimaging data will be collected for patients that are given low doses of dexmedetomidine in order to understand its analgesic effects.